Prognostic effect of early diagnostic splenectomy in Hodgkin's disease: a randomized trial

Area of Science:

• Oncology
• Hematology
• Surgical Oncology

Background:

• Hodgkin's disease (HD) is a cancer of the lymphatic system.
• Prognosis in HD can be uncertain, prompting investigations into additional diagnostic and therapeutic interventions.
• Early diagnostic splenectomy was explored as a method to potentially improve patient outcomes.

Purpose of the Study:

• To evaluate the impact of early diagnostic splenectomy on the prognosis of Hodgkin's disease (HD) patients with uncertain prognosis.
• To compare survival rates and recurrence patterns between patients who underwent splenectomy and those who did not.
• To assess the safety and potential complications associated with early diagnostic splenectomy in this patient group.

Main Methods:

• A randomized trial was conducted between January 1973 and April 1979.
• Sixty-seven patients with Hodgkin's disease and uncertain prognosis were enrolled.
• Thirty-one patients were randomized to receive early diagnostic splenectomy, while the remaining received standard treatment (total nodal irradiation).

Main Results:

• After a median observation period of 40 months, no significant difference in survival or recurrence rates was observed between the splenectomized and non-splenectomized groups.
• Patients who underwent splenectomy experienced relapses earlier compared to the control group.
• Two cases of pneumococcal septicemia were reported in the splenectomized patients, indicating a potential increased risk of infection.

Conclusions:

• Early diagnostic splenectomy does not improve the overall prognosis for Hodgkin's disease patients with uncertain prognosis when treated with total nodal irradiation.
• The procedure may be associated with earlier relapses and an increased risk of severe infections like pneumococcal septicemia.
• These findings suggest that early diagnostic splenectomy is not a beneficial intervention for this patient population.